Cantor Fitzgerald raised the firm’s price target on Nano-X Imaging (NNOX) to $12 from $11 and keeps an Overweight rating on the shares. After the company received FDA 510(k) expanded indication ...
Some results have been hidden because they may be inaccessible to you